No Data
No Data
12 Health Care Stocks Moving In Tuesday's After-Market Session
GainersRezolute (NASDAQ:RZLT) stock increased by 52.7% to $4.58 during Tuesday's after-market session. The company's market cap stands at $183.8 million. The company's, Q3 earnings came out 4 days ago
Maxim Group Sticks to Its Buy Rating for Acurx Pharmaceuticals (ACXP)
HC Wainwright & Co. : The Acurx Pharmaceuticals (ACXP.US) rating was reaffirmed, adjusted from buy to buy rating, and the target price was adjusted from $12.00 to $12.00.
HC Wainwright & Co. : The Acurx Pharmaceuticals (ACXP.US) rating was reaffirmed, adjusted from buy to buy rating, and the target price was adjusted from $12.00 to $12.00.
HC Wainwright & Co. Reiterates Buy on Acurx Pharmaceuticals, Maintains $12 Price Target
HC Wainwright & Co. analyst Ed Arce reiterates Acurx Pharmaceuticals (NASDAQ:ACXP) with a Buy and maintains $12 price target.
Acurx Pharmaceuticals Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/16/2024 433.33% HC Wainwright & Co. $12 → $12 Reiterates Buy → Buy 03/19/2024 433.33% HC Wainwright & C
Buy Rating Affirmed for Acurx Pharmaceuticals Amid Promising CDI Drug Candidate Progress and Solid Financials